Viewing Study NCT06319950


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-28 @ 10:17 AM
Study NCT ID: NCT06319950
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-20
First Post: 2024-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases
Sponsor: Taizhou Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module